DE60331882D1 - Antikörper zur Identifizierung und/oder Isolierung von wenigstens einer Zellpopulation ausgewählt aus hämatopoetischen Stammzellen, neuronalen Stammzellen, progenitoren neuronalen Zellen, Mesenchym-Stammzellen und mesenchym-progenitoren Stammzellen - Google Patents

Antikörper zur Identifizierung und/oder Isolierung von wenigstens einer Zellpopulation ausgewählt aus hämatopoetischen Stammzellen, neuronalen Stammzellen, progenitoren neuronalen Zellen, Mesenchym-Stammzellen und mesenchym-progenitoren Stammzellen

Info

Publication number
DE60331882D1
DE60331882D1 DE60331882T DE60331882T DE60331882D1 DE 60331882 D1 DE60331882 D1 DE 60331882D1 DE 60331882 T DE60331882 T DE 60331882T DE 60331882 T DE60331882 T DE 60331882T DE 60331882 D1 DE60331882 D1 DE 60331882D1
Authority
DE
Germany
Prior art keywords
stem cells
neuronal
mesenchymal
progenitor
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60331882T
Other languages
English (en)
Inventor
Hans-Joerg Dr Buehring
Reiner Dr Lammers
Selim Dr Kuci
Tim Conze
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=31502534&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60331882(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of DE60331882D1 publication Critical patent/DE60331882D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE60331882T 2002-09-04 2003-08-26 Antikörper zur Identifizierung und/oder Isolierung von wenigstens einer Zellpopulation ausgewählt aus hämatopoetischen Stammzellen, neuronalen Stammzellen, progenitoren neuronalen Zellen, Mesenchym-Stammzellen und mesenchym-progenitoren Stammzellen Expired - Lifetime DE60331882D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10242146A DE10242146A1 (de) 2002-09-04 2002-09-04 Antikörper zur Identifizierung und/oder Isolierung von hämatopoetischen Stammzellen

Publications (1)

Publication Number Publication Date
DE60331882D1 true DE60331882D1 (de) 2010-05-12

Family

ID=31502534

Family Applications (2)

Application Number Title Priority Date Filing Date
DE10242146A Ceased DE10242146A1 (de) 2002-09-04 2002-09-04 Antikörper zur Identifizierung und/oder Isolierung von hämatopoetischen Stammzellen
DE60331882T Expired - Lifetime DE60331882D1 (de) 2002-09-04 2003-08-26 Antikörper zur Identifizierung und/oder Isolierung von wenigstens einer Zellpopulation ausgewählt aus hämatopoetischen Stammzellen, neuronalen Stammzellen, progenitoren neuronalen Zellen, Mesenchym-Stammzellen und mesenchym-progenitoren Stammzellen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE10242146A Ceased DE10242146A1 (de) 2002-09-04 2002-09-04 Antikörper zur Identifizierung und/oder Isolierung von hämatopoetischen Stammzellen

Country Status (9)

Country Link
US (5) US7541030B2 (de)
EP (2) EP1396501B1 (de)
AT (1) ATE462728T1 (de)
CY (1) CY1110144T1 (de)
DE (2) DE10242146A1 (de)
DK (1) DK1396501T3 (de)
ES (1) ES2344982T3 (de)
PT (1) PT1396501E (de)
SI (1) SI1396501T1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10242338A1 (de) * 2002-09-09 2004-03-18 Eberhard-Karls-Universität Tübingen Universitätsklinikum Antikörper zur Isolierung und/oder Identifizierung mesenchymaler Stammzellen und Verfahren zur Isolierung und/oder Identifizierung mesenchymaler Stammzellen
KR100748363B1 (ko) * 2005-10-21 2007-08-09 삼성에스디아이 주식회사 점화장치를 갖는 연료개질 시스템
TWI412375B (zh) * 2009-08-28 2013-10-21 Roche Glycart Ag 人類化抗ｃｄｃｐ１抗體
TW201113037A (en) * 2009-08-28 2011-04-16 Hoffmann La Roche Antibodies against CDCP1 for the treatment of cancer
KR101383090B1 (ko) * 2013-07-11 2014-04-08 주식회사 이바이오젠 액상 항원―항체 반응을 이용한 다량의 단백질 발현 분석 방법
WO2015082446A1 (en) 2013-12-02 2015-06-11 F. Hoffmann-La Roche Ag Treatment of cancer using an anti-cdcp1 antibody and a taxane
WO2016131856A1 (en) 2015-02-18 2016-08-25 F. Hoffmann-La Roche Ag Immunoconjugates for specific induction of t cell cytotoxicity against a target cell
CN110234348A (zh) * 2016-12-16 2019-09-13 蓝鳍生物医药公司 抗-含cub结构域蛋白1(cdcp1)抗体、抗体药物缀合物及其使用方法
US10928391B2 (en) * 2017-06-06 2021-02-23 The Cleveland Clinic Foundation CD318 as a marker for, and CD318 inhibition as a treatment for, autoimmune disease
WO2021132427A1 (ja) * 2019-12-27 2021-07-01 株式会社カイオム・バイオサイエンス 抗ｃｄｃｐ１抗体
LU500787B1 (en) 2021-10-26 2023-04-27 Univ Hamburg Eppendorf Uke Isolation and detection of cdcp1 positive circulating tumor cells

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4844893A (en) * 1986-10-07 1989-07-04 Scripps Clinic And Research Foundation EX vivo effector cell activation for target cell killing
WO2000006698A1 (en) 1998-07-30 2000-02-10 Human Genome Sciences, Inc. 98 human secreted proteins
AU4441799A (en) * 1998-06-15 2000-01-05 Research Foundation Of The State University Of New York, The Monoclonal antibodies that recognize antigens associated with tumor metastasis
EP1074617A3 (de) 1999-07-29 2004-04-21 Research Association for Biotechnology Primers für Synthese von ganzen-Länge cDNS und deren Anwendung
JP2004522404A (ja) 1999-12-01 2004-07-29 ジェネンテック・インコーポレーテッド 分泌及び膜貫通ポリペプチドとそれをコードしている核酸
AU2001233041A1 (en) 2000-01-25 2001-08-07 Hyseq, Inc. Novel nucleic acids and polypeptides
US6436703B1 (en) 2000-03-31 2002-08-20 Hyseq, Inc. Nucleic acids and polypeptides
US20020142003A1 (en) * 2000-07-07 2002-10-03 Norbert Schweifer Tumor-associated antigen (B345)
WO2002004508A1 (de) * 2000-07-07 2002-01-17 Boehringer Ingelheim International Gmbh Tumorassoziiertes antigen (b345), gekennzeichnet durch eine aminosäuresequenz wie in seq. id. no. 4
CA2516366A1 (en) * 2003-02-19 2004-09-02 Novartis Ag Glycorpotein antigen sima135 expressed in metastatic human tumor cells

Also Published As

Publication number Publication date
EP1396501B1 (de) 2010-03-31
EP2206729A1 (de) 2010-07-14
US20130267687A1 (en) 2013-10-10
CY1110144T1 (el) 2015-01-14
US7741114B2 (en) 2010-06-22
US20150045541A1 (en) 2015-02-12
US20040053343A1 (en) 2004-03-18
ES2344982T3 (es) 2010-09-13
PT1396501E (pt) 2010-05-17
SI1396501T1 (sl) 2010-07-30
US20090181033A1 (en) 2009-07-16
DE10242146A1 (de) 2004-03-18
DK1396501T3 (da) 2010-06-21
US7541030B2 (en) 2009-06-02
US20100179306A1 (en) 2010-07-15
EP1396501A1 (de) 2004-03-10
ATE462728T1 (de) 2010-04-15

Similar Documents

Publication Publication Date Title
CY1110144T1 (el) Αντισωματα για την ταυτοποιηση και/ή την απομονωση τουλαχιστον ενος κυτταρικου πληθυσμου ο οποιος επιλεγεται απο την ομαδα την περιλαμβανουσα αιμοποιητικα βλαστοκυτταρα, νευρικα βλαστοκυτταρα, νευρικα αρχεγονα κυτταρα, μεσεγχυματικα βλαστοκυτταρα και μεσεγχυματικα αρχεγονα κυτταρα
RS52769B (sr) Kompozicije i postupci za povećanje mineralizacije kostiju
NZ591636A (en) Sclerostin binding agents
RS80704A (en) ANTI- av?6.ANTIBODIES
ATE248605T1 (de) Für e-selectin und p-selectin spezifische kreuzreaktive monoklonale antikörper
MXPA06010673A (es) Reduccion del riesgo de anticuerpos humanos anti-humano a traves de manipulacion del gen v.
ATE412432T1 (de) Internalisierende erbb2 antikörper
DK0933082T3 (da) Fremgangsmåde til manipulation af celledifferentiering
UA94576C2 (ru) Выделенное антитело, которое связывается с igf-1r, композиция, которая его содержит, и способы, которые касаются антител
PL374311A1 (en) Methods for purifying protein
EP2186884A3 (de) Monoklonale Antikörpergegen HCV Kernantigen
DE60130538D1 (de) Humanisierte antikörper gegen ccr2 und verfahren zur deren verwendung
EA200500647A1 (ru) Антитела, связывающие клеточные полипептиды ca 125/0772p, и способы их применения
DK1414858T3 (da) Kamelid-enkeltkæde-VHH-antistoffer, fremgangsmåde til fremstilling heraf i et pattedyr samt anvendelser heraf
ATE480562T1 (de) Veränderung von fcrn-bindungsaffinitäten oder von serumhalbwertszeiten von antikörpern mittels mutagenese
SI1899378T1 (sl) IL-1Beta vezavna protitelesa in njihovi fragmenti
EA200870072A1 (ru) ПРОТИВОВОСПАЛИТЕЛЬНЫЕ dAb
ATE277083T1 (de) Antikörper, die spezifisch für fullerene sind
GB0309126D0 (en) Clostridium difficile focussed antibodies
DE69933565D1 (de) Serinprotease-spzifischer moniklonaler antikörper und seine verwendung
WO2004025293A3 (de) Antikörper zur isolierung und/oder identifizierung mesenchymaler stammzellen und verfahren zur isolierung und/oder identifizierung mesenchymaler stammzellen
ATE346865T1 (de) Zusammensetzungen und verfahren zur herstellung monoklonaler antikörper, repräsentativ für einen spezifischen zelltyp
ATE533788T1 (de) Antikörper gegen cd44vra und methoden zu ihrer verwendung
WO2022133191A3 (en) Protein compositions and methods for producing and using the same
TH87431B (th) แอนติบอดีชนิดแอนติ-il-12, เอพิโทป, สารผสม, วิธี และการใช้

Legal Events

Date Code Title Description
8363 Opposition against the patent